Immunotherapy is emerging as a novel modality for controlling cancer and has been proposed as becoming the fourth cornerstone of cancer treatment along with surgery, radiotherapy, and chemotherapy.

Join Katalin Kelemen, MD, PhD and Ruben A. Mesa, MD from Mayo Clinic Cancer Center as they present their expertise on a range of cases pertaining to myeloproliferative neoplasms, with a specific focus on myelofibrosis.

Join Prashant Kapoor, MD and Shaji Kumar, MD from Mayo Clinic Cancer Center as they present their expertise on a range of cases pertaining to multiple myeloma.

Join Gregory Daniels, MD, PhD and Brian Hinds, MD from the University of California, San Diego as they present their expertise on a range of cases pertaining to melanoma.

Join Richard Penson, MD and Laura Sullivan, RN from Massachusetts General Hospital Cancer Center as they present their expertise on a range of cases pertaining to ovarian cancer.

Join Kalpana Devaraj, MD and Wells Messersmith, MD from University of Colorado Cancer Center as they present their expertise on a range of cases pertaining to colorectal cancer.

Join David D. Chism, MD, MS and Peter E. Clark from Vanderbilt-Ingram Cancer Center as they present their expertise on a range of cases pertaining to bladder cancer.

Join Suzanne George, MD and Chandrajit P. Raut, MD, MSc from Dana-Farber Cancer Institute as they present their expertise on a range of cases pertaining to sarcoma.

This series is designed to educate healthcare professionals on current and emerging scientific data so that they can make evidence-based decisions about screening and treatment for patients with non-small cell lung cancer (NSCLC).